header logo image

Point of Care Molecular Diagnostics Device Market Industry Analysis and Forecast (2019 to 2026) by… – Azizsalon News

June 1st, 2020 6:45 pm

Point of Care Molecular Diagnostic Device Market was valued at USD635.5 million in 2018 and is estimated to grow at a CAGR of XX% from 2018 to 2026.Point of Care Molecular Diagnostics Device Market, By RegionA point-of-care (POC) test is performed at or near the site where a patient initially encounters the health care system. It has a rapid turnaround time (approximately 15 min) and provides actionable information that can lead to better patient management.

REQUEST FOR FREE SAMPLE REPORT:https://www.maximizemarketresearch.com/request-sample/10995/

Some of the key market drivers include the increasing technological advancements, ability to diagnose infectious diseases at sites with a limited infrastructure, availability of clinical evidence for the safety and efficacy procedures, patients awareness about better healthcare options and readiness for rising healthcare expenditures, changing technology and innovation, changing demographics and lifestyles leading to an increased prevalence of peripheral vascular diseases, adoption of new products, rising demand for advanced medical instruments, geriatric population.

Point of Care Molecular Diagnostics Device Market is segmented by product & service, technology, application, end user, and region. Point of Care Molecular Diagnostics Device Market has the largest usage in Physician Offices, Hospital Emergency Departments & Intensive Care Units, and Research Institutes

Geographically, global point of care molecular diagnostics device market is classified into North America, Europe, Asia Pacific (APAC), and the Rest of the World (RoW). In 2018, North America is anticipated to have the largest share in the global adhesion barrier market. The largest ratio of the North American market can mostly be attributed to the high prevalence of technologically advanced medical framework, sophisticated insurance & co-payment system & high R&D investment by governments and private funding organizations for the development of POC MDx tests are major factors responsible for the regions dominant market position. Availability of clinical evidence for the safety and efficacy of point of care molecular diagnostics procedures, transmuting technology and innovation.

Asia Pacific market is expected to grow at the fastest rate during the forecast period owing to the increasing demand for POC test. Many minuscule players are looking forward to investment in the Asia Pacific market due to sizable patient pool and incremental utilization of global adhesion barrier market devices.

DO INQUIRY BEFORE PURCHASING REPORT HERE:https://www.maximizemarketresearch.com/inquiry-before-buying/10995/

The key players in the Point of Care Molecular Diagnostics Device Market include Roche Diagnostics (Switzerland), Biomerieux (France), Danaher (US), Abbott Laboratories (US), Quidel (US) and Meridian Bioscience (US).

The years that have been considered for the study are:

Base year 2017 Estimated year 2018 Forecast period 2018 to 2026

Target Audience: POC Molecular Diagnostics Manufacturers Physicians Research Institutes Diagnostics Suppliers Market Research and Consulting Firms Regulatory Bodies Venture CapitalistsPoint of Care Molecular Diagnostics Device Market- Key Segment:

Point of Care Molecular Diagnostics Device Market, By Product & Service:

o Assays & Kitso Instruments/Analyserso Services & SoftwarePoint of Care Molecular Diagnostics Device Market, By Application:

o Respiratory diseaseso STDso HAIso Oncologyo HepatitisPoint of Care Molecular Diagnostics Device Market, By Technology:

o RT-PCRo INAATo Others Technologies Point of Care Molecular Diagnostics Device Market, By End User:

o Physician Officeso Hospital Emergency Departments & Intensive Care Unitso Research Instituteso Other End User

Company Profiles:

Abacus Diagnostica Advanced Liquid Logic (Illumina) Ahram Biosystems Akonni Biosystems Alere (Abbott) Amplino Analytik Jena Aquila Diagnostic Systems Atlas Genetics Axxin Becton, Dickinson & Co. (BD) Biocartis Biomeme bioMrieux Canon BioMedical Cepheid Coris BioConcept Coyote Bioscience Curetis DestiNA Genomics Diagnostics For All Diagnostics for the Real World DiaSorin DiAssess DNA Electronics DxNAPoint of Care Molecular Diagnostics Device Market, By Region

North America U.S Canada

Europe Germany France UK Italy Spain Russia Rest of Europe

Asia Pacific Japan China India South Korea Australia Rest of Asia Pacific

Rest of the World (ROW): Middle-East Africa Latin America

MAJOR TOC OF THE REPORT

Chapter One: Point of Care Molecular Diagnostics Device Market Overview

Chapter Two: Manufacturers Profiles

Chapter Three: Global Point of Care Molecular Diagnostics Device Market Competition, by Players

Chapter Four: Global Point of Care Molecular Diagnostics Device Market Size by Regions

Chapter Five: North America Point of Care Molecular Diagnostics Device Revenue by Countries

Chapter Six: Europe Point of Care Molecular Diagnostics Device Revenue by Countries

Chapter Seven: Asia-Pacific Point of Care Molecular Diagnostics Device Revenue by Countries

Chapter Eight: South America Point of Care Molecular Diagnostics Device Revenue by Countries

Chapter Nine: Middle East and Africa Revenue Point of Care Molecular Diagnostics Device by Countries

Chapter Ten: Global Point of Care Molecular Diagnostics Device Market Segment by Type

Chapter Eleven: Global Point of Care Molecular Diagnostics Device Market Segment by Application

Chapter Twelve: Global Point of Care Molecular Diagnostics Device Market Size Forecast (2019-2026)

Browse Full Report with Facts and Figures of Point of Care Molecular Diagnostics Device Market Report at:https://www.maximizemarketresearch.com/market-report/point-of-care-molecular-diagnostics-device-market/10995/

About Us:

Maximize Market Research provides B2B and B2C market research on 20,000 high growth emerging technologies & opportunities in Chemical, Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Vikas Godage

Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: sales@maximizemarketresearch.com

Contact: +919607065656/ +919607195908

Website: http://www.maximizemarketresearch.com

Connect With us at LinkedInLinkedIn

Connect with us at FacebookFacebook

Contact With Us at TwitterTwitter

See more here:
Point of Care Molecular Diagnostics Device Market Industry Analysis and Forecast (2019 to 2026) by... - Azizsalon News

Related Post

Comments are closed.


2024 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick